SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-016941
Filing Date
2022-04-29
Accepted
2022-04-29 16:07:04
Documents
4
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20002921x2_def14a.htm DEF 14A 924801
2 logo_rocketpharma.jpg GRAPHIC 25772
3 ny20002921x2-pc_1.jpg GRAPHIC 595524
4 ny20002921x2-pc_2.jpg GRAPHIC 661172
  Complete submission text file 0001140361-22-016941.txt   2691260
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36829 | Film No.: 22875261
SIC: 2834 Pharmaceutical Preparations